Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Barclays PLC
  6. News
  7. Summary
    BARC   GB0031348658

BARCLAYS PLC

(BARC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Activist Bramson abandons tussle with Barclays, selling stake

05/07/2021 | 02:29am EDT
FILE PHOTO: FILE PHOTO: FILE PHOTO: A Barclays bank building is seen at Canary Wharf in London

(Adds investor comment, further context on Sherborne fund)

LONDON, May 7 (Reuters) - Activist investor Edward Bramson has sold his firm's 6% stake in Barclays, disbanding a three-year effort to overhaul the British bank and ending a stand-off with chief executive Jes Staley.

Bramson's fund, Sherborne Investors, had pressured Staley since 2018 to scale back investment banking and demanded his removal over his links to U.S. financier and registered sex offender Jeffrey Epstein, but Bramson struggled to gain much traction.

The value of the Sherborne vehicle dedicated to the Barclays stake has fallen by around 150 million pounds ($209 million) compared to the 700 million pounds it raised when it was formed in 2017.

The fund, in which UK asset managers Aviva and Schroders have stakes, said it had identified another company to invest in and has begun building a position in that firm, which it did not name.

Barclays declined to comment.

"Business is not a science and so people of goodwill may, therefore, sometimes differ. In that spirit, Sherborne Investors expresses its most sincere wish that things will turn out well for Barclays, its employees, and its investors," Sherborne Investors Management said in a statement.

One top 20 investor in Barclays, who declined to be named, said a recent rally in Barclays' shares on investor bets of a strong recovery from the COVID-19 pandemic had provided Bramson with an exit route and predicted he would opt for a less complex next target.

Barclays shares have fallen roughly 15% since Sherborne first declared its stake in Barclays in March 2018.

The stock was up 2% on Friday.

'THE WAR IS OVER'

When Sherborne first invested, Barclays had been under pressure to bolster profits after Staley's aggressive push in investment banking since he joined in 2015 failed to significantly lift returns.

Barclays was Bramson's largest target to date. He engineered turnarounds at smaller firms including British private equity firm Electra after forcing his way onto the board. But a bid by Bramson for a board seat at Barclays was emphatically rejected by shareholders in 2019.

A strong showing by the investment bank helped it weather the COVID-19 pandemic, bolstering Staley's argument that it needed a diversified business to cope in a recession.

"The war is over," wrote Ian Gordon, a banking analyst at Investec.

"We sense that investor appetite for a further round of heavy restructuring charges to execute such a repositioning of the group was limited."

Bramson also urged Barclays' board to replace Staley after the UK regulator said it was examining his links with Jeffrey Epstein, but failed to win support.

Staley has said he regrets having a professional relationship with Epstein, who killed himself while awaiting trial on sex trafficking charges.

Sherborne initially invested 580 million pounds in Barclays' shares and derivatives but the investment did little to lift its fortunes.

The net asset value of the Sherborne fund is currently 79 pence per share, it said, compared to 99 pence in December 2017 before it made the Barclays investment. ($1 = 0.7183 pounds) (Reporting By John O'Donnell in Frankfurt and Iain Withers and Carolyn Cohn in London; editing by Rachel Armstrong and Elaine Hardcastle)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
AVIVA PLC -0.05% 414.7 Delayed Quote.27.58%
BARCLAYS PLC 0.93% 174.4 Delayed Quote.17.81%
ELECTRA LIMITED 0.60% 185610 Delayed Quote.5.07%
SCHRODERS PLC 0.09% 3533 Delayed Quote.5.78%
SHERBORNE INVESTORS (GUERNSEY) C LIMITED 0.00% 60.25 Delayed Quote.44.48%
All news about BARCLAYS PLC
12:18pCLOVER HEALTH INVESTMENTS  : Tiger Global-backed Bright Health falls in debut, v..
RE
07:41aCREST NICHOLSON  : British homebuilder Crest Nicholson raises 2021 profit foreca..
RE
07:11aWACKER CHEMIE AG  : Gets a Buy rating from Barclays
MD
06:31aBARCLAYS  : appoints Tobias Åkermark as Head of Nordic Banking and Country CEO S..
PU
04:41aFTSE Gains, Pound Expected to Rise Vs Euro on BOE Tapering
DJ
03:29aGLAXOSMITHKLINE  : Barclays reiterates its Sell rating
MD
01:54aSlovenia Issues Maiden Sustainability-Linked $1.2 Billion Bond
MT
01:17aANALYSIS : Fed's mixed messages on inflation unsettle investors
RE
12:43aASSURA  : Prices Maiden $419 Million Sustainability-Linked Bond
MT
12:35aTiger Global-backed Bright Health raises $924 million in U.S. IPO
RE
More news
Financials
Sales 2021 21 243 M 29 570 M 29 570 M
Net income 2021 3 921 M 5 458 M 5 458 M
Net Debt 2021 - - -
P/E ratio 2021 7,65x
Yield 2021 3,60%
Capitalization 29 613 M 41 167 M 41 221 M
Capi. / Sales 2021 1,39x
Capi. / Sales 2022 1,37x
Nbr of Employees 83 000
Free-Float 99,6%
Chart BARCLAYS PLC
Duration : Period :
Barclays PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BARCLAYS PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 1,74 GBX
Average target price 214,15 GBX
Spread / Average Target 12 179%
EPS Revisions
Managers and Directors
NameTitle
James Edward Staley Group Chief Executive Officer & Executive Director
Tushar Morzaria Group Finance Director & Executive Director
Nigel Paul Higgins Group Chairman
Mark Ashton Rigby Group Chief Operating Officer
Laura Padovani Group Chief Compliance Officer
Sector and Competitors